Navigation Links
Reportlinker Adds Johnson & Johnson: PharmaVitae Profile
Date:9/23/2010

able 24: Simponi: overview 96

Table 25: Simponi: sales forecast ($m), 2009-15 97

Table 26: Velcade: overview 98

Table 27: Velcade: sales forecast ($m), 2009-15 99

Table 28: Remicade: overview 101

Table 29: Remicade: sales forecast ($m), 2009-15 102

Table 30: Procrit: overview 104

Table 31: Procrit: sales forecast ($m), 2009-15 105

Table 32: Risperdal: overview 107

Table 33: Risperdal: sales forecast ($m), 2009-15 108

Table 34: Prezista: overview 111

Table 35: Prezista: sales forecast ($m), 2009-15 112

Table 36: Johnson & Johnson's R&D pipeline (Phase I-registration) 114

Table 37: Total Remicade sales forecast ($m), 2009-15 116

Table 38: Exchange rates, 2010 118

List of Figures Figure 1: The PharmaVitae Explorer 3

Figure 2: Johnson & Johnson prescription pharmaceutical performance, sales ($m) and growth rate (%), 2003-15 6

Figure 3: Johnson & Johnson's financial performance ($m), 2003-15 7

Figure 4: Lifecycle management strategies boost key J&J franchises, 2003-15 ($m) 10

Figure 5: Johnson & Johnson prescription pharmaceutical sales by stage, 2003-15 ($m) 13

Figure 6: J&J's strategic options for growth 15

Figure 7: Johnson & Johnson SWOT analysis 18

Figure 8: Current corporate structure 42

Figure 9: Current corporate structure 45

Figure 10: Johnson & Johnson prescription pharmaceutical performance, sales ($m) and growth rate (%), 2003-15 47

Figure 11: Johnson & Johnson Key product sales ($m), 2003-15 49

Figure 12: Johnson & Johnson key sales growth drivers and resistors ($m), 2003-09 52

Figure 13: Johnson & Johnson key sales growth drivers and resistors ($m), 2009-15 56

Figure 14: Johnson & Johnson prescription pharmaceutical sales by therapy area ($m), 2003-15 59

Figure 15: Johnson & Johnson prescription phar
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile
2. Reportlinker Adds Genzyme Corporation: PharmaVitae Profile
3. Reportlinker Adds Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Global Markets
4. Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets
5. Reportlinker Adds Actelion Ltd: PharmaVitae Profile
6. Reportlinker Adds Pfizer Inc.: PharmaVitae Profile
7. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
8. Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile
9. Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012
10. Reportlinker Adds The Impact of US Healthcare Reform on Pharma: Analyzing the Effects
11. Reportlinker Adds IP Overview - "Monoclonal Antibodies against digestive system cancers" Patent Landscape 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 2014  Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... European Commission (the "EC") to extend the deadline for ... by a limited number of days in order to ... Deadline extensions are not uncommon in such in-depth ... authorities to facilitate their review of the pending transaction ...
(Date:11/18/2014)... Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced today that ... 2014 at 9:00 a.m. Eastern Time to discuss the ISIS-FXI ... Society of Hematology Annual Meeting and Exposition.  ... or access the webcast at www.isispharm.com .  A webcast ... same address. ABOUT ISIS PHARMACEUTICALS, INC. ...
(Date:11/18/2014)... 18, 2014  AgeneBio, a pharmaceutical company developing ... restore brain function, today announced that the Company,s ... , PhD, has received the Society for Neuroscience,s ... 35 years, Dr. Gallagher,s research at Johns Hopkins ... Hill has led to advancements in the field ...
Breaking Medicine Technology:Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 2Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 4Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 5Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 3AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 2AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 3
(Date:11/18/2014)... 18, 2014 A+ Secure Packaging, ... nutraceutical, dietary supplements and more, announced today that ... Good Manufacturing Practices (GMP) Registration for dietary supplements ... from NSF International verifies the A+ Secure Packaging ... compliance requirements of its clients by demonstrating the ...
(Date:11/18/2014)... Newport Beach, CA (PRWEB) November 18, 2014 ... settle into new routines, many people look at fall ... the holidays. Dr. Kevin Sadati , Orange County ... at this Newport Beach practice. At the Gallery ... his patients taking advantage of his non-invasive cosmetic surgery ...
(Date:11/18/2014)... Haelle HealthDay Reporter MONDAY, ... experience a severe abusive head trauma before the age of ... new study. In addition, among those who survive ... the study found. Abusive head trauma includes shaken baby ... suffers head injuries, according to background information in the study. ...
(Date:11/18/2014)... HealthDay Reporter , MONDAY, Nov. 17, ... not have significant heart-health benefits for older people, new ... than 14,000 Japanese people aged 60 to 85, found ... attacks and strokes between people who took aspirin and ... prevention with daily low-dose aspirin does not reduce the ...
(Date:11/18/2014)... Dennis Thompson HealthDay ... Heart attack and stroke patients can safely take aspirin combined ... blood-thinning combination won,t increase a patient,s risk of early death, ... meeting of the American Heart Association in Chicago. The report ... . Analysis of data from more than a dozen ...
Breaking Medicine News(10 mins):Health News:A+ Secure Packaging, LLC Earns NSF International Good Manufacturing Practices (GMP) Registration for Dietary Supplements and Certification for Sport 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 4Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 3Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 2Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 3
... News) -- Many children who,ve lost a sister or brother ... as a result of the experience, new research finds. ... Nursing , researchers from Nationwide Children,s Hospital in Columbus, Ohio, ... a sibling impacted them one year later. Siblings were ...
... New breast cancer screening guidelines for women at ... (Canadian Medical Association Journal) (pre-embargo link only) ... women aged 40-49 and extend the screening interval ... practice, to every 2 to 3 years for ...
... 2011) -- Older adults receiving home health care may be ... their age. In fact, nearly 40 percent of seniors receiving ... least one prescription medication that is considered potentially inappropriate to ... Internal Medicine has revealed. The study,s researchers, led ...
... find the main culprit behind the dry, irritated eyes, ... of the population., It,s called Sjgren,s syndrome, a painful ... 6.5 years to diagnose and is difficult to treat. ... how it develops should improve diagnosis and treatment. , ...
... of Michigan Medical School and MedImmune, the global biologics ... work together on a broad range of projects. ... of the nation,s top medical research institutions together with ... biologic therapies. UMMS and MedImmune scientists will ...
... Institutet have developed a new method for counting molecules. ... DNA molecules is a fundamental task in molecular biology ... in cells. Thus, improved measurement techniques are crucial for ... very difficult to detect small individual molecules in a ...
Cached Medicine News:Health News:Siblings Deeply Affected By Child's Cancer Death 2Health News:New breast cancer screening guidelines released 2Health News:New breast cancer screening guidelines released 3Health News:Older adults in home health care at elevated risk for unsafe meds 2Health News:Researchers search for culprit behind dry eyes, mouths and more 2Health News:Researchers search for culprit behind dry eyes, mouths and more 3Health News:U-M Medical School and MedImmune join forces to accelerate search for new therapies 2Health News:A better way to count molecules discovered 2
The PillCam™ ESO video capsule is specifically designed to view the inner lining of the Esophagus. The capsule is equipped with miniature cameras on both ends and is about the size of a multi-v...
... Radi invented the guidewire-mounted pressure ... way. PressureWire5 Sensor is the only ... pressure, temperature and flow. With significantly ... serves as your primary guidewire, as ...
... ultrasound and MRI-guided vacuum assisted breast biopsies ... the patented, FDA-cleared ATEC system for a ... method of breast biopsy. Its compassionate care ... trust YOU.,9 Gauge Handpieces: Useful for biopsy ...
Three-spring evacuator kits with silicone drains, 10 in. hole pattern, trocar and Y-connector tubing...
Medicine Products: